![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/POLYMED.png)
Share the post "POLY MEDICURE ‘s Q3 2024-25 Latest News: Profit Up by 31.08% Year-on-Year"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 24.92 % in the past year, substantial increase in net sales/revenue by 1 %. 🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 31.58 %. Marginal decrease of -16.46% in other income during this quarter. 🔹 Profit over the Year and quarter: Significant improvement in profitability for POLY MEDICURE LTD.. Notable increase of 31.09 % in net profit Year to Year, POLY MEDICURE LTD.’s profitability dropped by -2.55 % Quarter to Quarter. 🔹 EPS over the Year and quarter: EPS increased by 25.07 % Year to Year. EPS decreased by -5.88 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 339.598 Cr | Rs. 420.015 Cr | Rs. 424.212 Cr | + 1 % | + 24.92 % |
| Expenses | Rs. 249.37 Cr | Rs. 304.69 Cr | Rs. 309.67 Cr | + 1.63 % | + 24.18 % |
| Operating Profit | Rs. 90.23 Cr | Rs. 115.33 Cr | Rs. 114.54 Cr | -0.68 % | + 26.94 % |
| OPM % | 26.57 % | 27.46 % | 27 % | -0.46 % | + 0.43 % |
| Other Income | Rs. 16.568 Cr | Rs. 26.098 Cr | Rs. 21.801 Cr | -16.46 % | + 31.58 % |
| Interest | Rs. 3.47 Cr | Rs. 3.34 Cr | Rs. 3.33 Cr | -0.3 % | -4.03 % |
| Depreciation | Rs. 16.21 Cr | Rs. 20.85 Cr | Rs. 21.51 Cr | + 3.17 % | + 32.7 % |
| Profit before tax | Rs. 87.12 Cr | Rs. 117.24 Cr | Rs. 111.5 Cr | -4.9 % | + 27.98 % |
| Tax % | 26.18 % | 26.04 % | 25.11 % | -0.93 % | -1.07 % |
| Net Profit | Rs. 65.02 Cr | Rs. 87.46 Cr | Rs. 85.23 Cr | -2.55 % | + 31.08 % |
| EPS in Rs | Rs. 6.77 | Rs. 9.01 | Rs. 8.48 | -5.88 % | + 25.26 % |
Today, we’re looking at POLY MEDICURE LTD.’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 24.92 %. However, it did see a marginal increase of 1 % from the previous quarter. Expenses ticked up slightly by 1.63 % quarter-on-quarter, aligning with the annual rise of 24.18 %. Operating profit, while up 26.94 % compared to last year, faced a quarter-on-quarter dip of -0.68 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 0.43 %, but a shrinkage of -0.46 % sequentially. Other income fell by -16.46 % compared to the last quarter, despite an annual growth of 31.58 %. Interest expenses dropped significantly by -0.3 % from the previous quarter, yet the year-over-year decrease remains at a moderate -4.03 %. Depreciation costs climbed by 3.17 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 32.7 %. Profit before tax grew annually by 27.98 % but saw a reduction from the preceding quarter by -4.9 %.
Tax expenses as a percentage of profits decreased slightly by -1.07 % compared to last year, with a more notable quarter-on-quarter decrease of -0.93 %. Net profit rose by 31.08 % year-on-year but witnessed a -2.55 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 25.26 % but a quarterly fall of -5.88 %. In summary, POLY MEDICURE LTD.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 339.598 Cr | Rs. 420.015 Cr | Rs. 424.212 Cr | + 1 % | + 24.92 % |
| Expenses | Rs. 249.37 Cr | Rs. 304.69 Cr | Rs. 309.67 Cr | + 1.63 % | + 24.18 % |
| Operating Profit | Rs. 90.23 Cr | Rs. 115.33 Cr | Rs. 114.54 Cr | -0.68 % | + 26.94 % |
| Net Profit | Rs. 65.02 Cr | Rs. 87.46 Cr | Rs. 85.23 Cr | -2.55 % | + 31.08 % |
| EPS in Rs | Rs. 6.77 | Rs. 9.01 | Rs. 8.48 | -5.88 % | + 25.26 % |
In reviewing POLY MEDICURE LTD.’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 24.92 % year-on-year growth, however, there was a minor increase of 1 % from the previous quarter. Expenses rose by 24.18 % compared to the previous year, with a 1.63 % increase quarter-on-quarter. Operating Profit surged by 26.94 % annually, and saw a -0.68 % decrease from the last quarter.
Net Profit showed yearly increase of 31.08 %, and experienced a -2.55 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 25.26 % annually, however dipped by -5.88 % compared to the last quarter. In essence, while POLY MEDICURE LTD. exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/PDMJEPAPER.png)
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/UPHOT.png)
